This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sudhir, K. Articles by Whitworth, J. A. Search for Related Content PubMed PubMed Citation Articles by Sudhir, K. Articles by Whitworth, J. A.

Hypertension, Vol 13, 416-421, Copyright © 1989 by American Heart Association

ARTICLES

Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function

K Sudhir, GL Jennings, MD Esler, PI Korner, PA Blombery, GW Lambert, B Scoggins and JA Whitworth
Clinical Research Unit, Baker Medical Research Institute, Prahran, Victoria, Australia.

Oral hydrocortisone increases blood pressure and enhances pressor responsiveness in normal human subjects. We studied the effects of 1 week of oral hydrocortisone (200 mg/day) on blood pressure, cardiac output, total peripheral resistance, forearm vascular resistance, and norepinephrine spillover to plasma in eight healthy male volunteers. Although diastolic blood pressure remained unchanged, systolic blood pressure increased from 119 to 135 mm Hg (SED +/- 3.4, p less than 0.01), associated with an increased cardiac output (5.85-7.73 l/min, SED +/- 0.46, p less than 0.01). Total peripheral vascular resistance fell from 15.1 to 12.2 mm Hg/l/min (SED +/- 1.03, p less than 0.05). Resting forearm vascular resistance remained unchanged, but the reflex response to the cold pressor test was accentuated, the rise in resistance increasing from 10.5 mm Hg/ml/100 ml/min (R units) before treatment to 32.6 R units after treatment (SED +/- 6.4, p less than 0.025). The rise in forearm vascular resistance accompanying intra- arterial norepinephrine (25, 50, and 100 ng/min) was also significantly greater after hydrocortisone, increasing from an average of 14.9 +/- 2.4 R units before treatment to 35.1 +/- 5.5 R units after hydrocortisone (SED +/- 6.0, p less than 0.05). A shift to the left in the dose-response relation and fall in threshold suggested increased sensitivity to norepinephrine after treatment. Measurement of resting norepinephrine spillover rate to plasma and norepinephrine uptake indicated that overall resting sympathetic nervous system activity was not increased. The rise in resting blood pressure with hydrocortisone is associated with an increased cardiac output (presumably due to increased blood volume).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. A. Mitchell, G. Lambert, N. H. Secher, P. B. Raven, J. van Lieshout, and M. D. Esler Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans J. Physiol., June 1, 2009; 587(11): 2589 - 2597. [Abstract] [Full Text] [PDF]

				B. R Walker Glucocorticoids and Cardiovascular Disease Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559. [Abstract] [Full Text] [PDF]

				R. Aras-Lopez, J. Blanco-Rivero, F. E. Xavier, M. Salaices, M. Ferrer, and G. Balfagon Dexamethasone Decreases Contraction to Electrical Field Stimulation in Mesenteric Arteries from Spontaneously Hypertensive Rats through Decreases in Thromboxane A2 Release J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1129 - 1136. [Abstract] [Full Text] [PDF]

				B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346. [Abstract] [Full Text] [PDF]

				P. Wellhoener, J. Born, H. L. Fehm, and C. Dodt Elevated Resting and Exercise-Induced Cortisol Levels after Mineralocorticoid Receptor Blockade with Canrenoate in Healthy Humans J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5048 - 5052. [Abstract] [Full Text] [PDF]

				M. L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E. A. Rosei, F. Mantero, and F. Fallo Left ventricular structural and functional characteristics in Cushing's syndrome J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2275 - 2279. [Abstract] [Full Text] [PDF]

				D. A. Scheuer and S. W. Mifflin Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1440 - R1449. [Abstract] [Full Text] [PDF]

				C. Dodt, B. Keyser, M. Molle, H. L. Fehm, and M. Elam Acute Suppression of Muscle Sympathetic Nerve Activity by Hydrocortisone in Humans Hypertension, March 1, 2000; 35(3): 758 - 763. [Abstract] [Full Text] [PDF]

				C. N. May and J. A. Bednarik Regional Hemodynamic and Endocrine Effects of Aldosterone and Cortisol in Conscious Sheep : Comparison With the Effects of Corticotropin Hypertension, August 1, 1995; 26(2): 294 - 300. [Abstract] [Full Text]

				E. Grossman and F. H. Messerli High Blood Pressure: A Side Effect of Drugs, Poisons, and Food Arch Intern Med, March 13, 1995; 155(5): 450 - 460. [Abstract] [PDF]